Human immunodeficiency virus monocyte-derived macrophages

Byrn RA, Kiesshng AA (1998) Analysis of human immunodeficiency virus in semen indications of a genetically distinct virus reservoir. J Reprod Immunol 41(1-2) 161-176 Carr JM, Hocking H, Li P, Burrell CJ (1999) Rapid and efficient celL-to-ceU transmission of human immunodeficiency vims infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265(2) 319-329... 

Xiong H, McCabe L, Skifter D, Monaghan DT, Gendelman HE (2003a) Activation of NRla/NR2B receptors by monocyte-derived macrophage secretory products Implications for human immunodeficiency virus type one-associated dementia. Neurosci Lett 341 246-250. 

Collman R, Hassan NF, Walker R et al. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med 1989 170 1149-1163. 

Fear W, Kesson A, Naif H et al. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998 72 1334-1344. 

Naif HM, Li S, Alali M et al. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J Virol 1999 73 4866-4881. 

Jiang Y, Jolly P. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages. J Hum Virol 1999 2 123-132. 

Adenallene and cytallene, two novel acyclic nucleoside derivatives active against human immunodeficiency virus (HTV) in T-cells and monocytes/macrophages ia vitro Further characterization of anti-viral and cytotoxic activity, in "Mechanisms of Action and Therapeutic Applications of Biologicals in Canco and Immune Deficiency Disorders", Alan R. Liss, Inc., 1989, p. 371. 

---